151 related articles for article (PubMed ID: 26866403)
1. Metabolomics analysis of exhaled breath condensate for discrimination between lung cancer patients and risk factor individuals.
Peralbo-Molina A; Calderón-Santiago M; Priego-Capote F; Jurado-Gámez B; Luque de Castro MD
J Breath Res; 2016 Feb; 10(1):016011. PubMed ID: 26866403
[TBL] [Abstract][Full Text] [Related]
2. Development of a method for metabolomic analysis of human exhaled breath condensate by gas chromatography-mass spectrometry in high resolution mode.
Peralbo-Molina A; Calderón-Santiago M; Priego-Capote F; Jurado-Gámez B; Luque de Castro MD
Anal Chim Acta; 2015 Aug; 887():118-126. PubMed ID: 26320793
[TBL] [Abstract][Full Text] [Related]
3. Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics.
López-Sánchez LM; Jurado-Gámez B; Feu-Collado N; Valverde A; Cañas A; Fernández-Rueda JL; Aranda E; Rodríguez-Ariza A
Am J Physiol Lung Cell Mol Physiol; 2017 Oct; 313(4):L664-L676. PubMed ID: 28619761
[TBL] [Abstract][Full Text] [Related]
4. Identification of metabolomics panels for potential lung cancer screening by analysis of exhaled breath condensate.
Peralbo-Molina A; Calderón-Santiago M; Priego-Capote F; Jurado-Gámez B; Luque de Castro MD
J Breath Res; 2016 Mar; 10(2):026002. PubMed ID: 27007686
[TBL] [Abstract][Full Text] [Related]
5. Analysis of cytokine pattern in exhaled breath condensate of patients with squamous cell lung carcinoma.
Barta I; Kullmann T; Csiszer E; Antus B
Int J Biol Markers; 2010; 25(1):52-6. PubMed ID: 20155714
[TBL] [Abstract][Full Text] [Related]
6. Clinical metabolomics of exhaled breath condensate in chronic respiratory diseases.
Maniscalco M; Fuschillo S; Paris D; Cutignano A; Sanduzzi A; Motta A
Adv Clin Chem; 2019; 88():121-149. PubMed ID: 30612604
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Ambient and Atmospheric Pressure Ion Sources for Cystic Fibrosis Exhaled Breath Condensate Ion Mobility-Mass Spectrometry Metabolomics.
Zang X; Pérez JJ; Jones CM; Monge ME; McCarty NA; Stecenko AA; Fernández FM
J Am Soc Mass Spectrom; 2017 Aug; 28(8):1489-1496. PubMed ID: 28364225
[TBL] [Abstract][Full Text] [Related]
8. Exhaled Breath Condensate pH in Lung Cancer, the Impact of Clinical Factors.
Bikov A; Lazar Z; Gyulai N; Szentkereszty M; Losonczy G; Horvath I; Galffy G
Lung; 2015 Dec; 193(6):957-63. PubMed ID: 26260979
[TBL] [Abstract][Full Text] [Related]
9. Exhaled breath condensate methods adapted from human studies using longitudinal metabolomics for predicting early health alterations in dolphins.
Borras E; Aksenov AA; Baird M; Novick B; Schivo M; Zamuruyev KO; Pasamontes A; Parry C; Foutouhi S; Venn-Watson S; Weimer BC; Davis CE
Anal Bioanal Chem; 2017 Nov; 409(28):6523-6536. PubMed ID: 29063162
[TBL] [Abstract][Full Text] [Related]
10. Exhaled breath analysis: novel approach for early detection of lung cancer.
Chan HP; Lewis C; Thomas PS
Lung Cancer; 2009 Feb; 63(2):164-8. PubMed ID: 18599152
[TBL] [Abstract][Full Text] [Related]
11. Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients.
Han W; Wang T; Reilly AA; Keller SM; Spivack SD
Respir Res; 2009 Sep; 10(1):86. PubMed ID: 19781081
[TBL] [Abstract][Full Text] [Related]
12. Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease.
Santini G; Mores N; Penas A; Capuano R; Mondino C; Trové A; Macagno F; Zini G; Cattani P; Martinelli E; Motta A; Macis G; Ciabattoni G; Montuschi P
Curr Top Med Chem; 2016; 16(14):1610-30. PubMed ID: 26693732
[TBL] [Abstract][Full Text] [Related]
13. Exhaled breath condensate biomarkers for lung cancer.
Campanella A; De Summa S; Tommasi S
J Breath Res; 2019 Aug; 13(4):044002. PubMed ID: 31282387
[TBL] [Abstract][Full Text] [Related]
14. Exhaled breath condensate pH in patients with lung cancer.
Antus B; Barta I
Lung Cancer; 2012 Feb; 75(2):178-80. PubMed ID: 21831475
[TBL] [Abstract][Full Text] [Related]
15. Exhaled breath analysis in suspected cases of non-small-cell lung cancer: a cross-sectional study.
Corradi M; Poli D; Banda I; Bonini S; Mozzoni P; Pinelli S; Alinovi R; Andreoli R; Ampollini L; Casalini A; Carbognani P; Goldoni M; Mutti A
J Breath Res; 2015 Jan; 9(2):027101. PubMed ID: 25634546
[TBL] [Abstract][Full Text] [Related]
16. Exhaled breath condensate to discriminate individuals with different smoking habits by GC-TOF/MS.
Peralbo-Molina A; Calderón-Santiago M; Jurado-Gámez B; Luque de Castro MD; Priego-Capote F
Sci Rep; 2017 May; 7(1):1421. PubMed ID: 28469199
[TBL] [Abstract][Full Text] [Related]
17. Exhaled breath condensate as a potential biomarker tool for idiopathic pulmonary fibrosis-a pilot study.
Rindlisbacher B; Strebel C; Guler S; Kollár A; Geiser T; Martin Fiedler G; Benedikt Leichtle A; Bovet C; Funke-Chambour M
J Breath Res; 2017 Nov; 12(1):016003. PubMed ID: 28775244
[TBL] [Abstract][Full Text] [Related]
18. The analysis of volatile organic compounds in exhaled breath and biomarkers in exhaled breath condensate in children - clinical tools or scientific toys?
van Mastrigt E; de Jongste JC; Pijnenburg MW
Clin Exp Allergy; 2015 Jul; 45(7):1170-88. PubMed ID: 25394891
[TBL] [Abstract][Full Text] [Related]
19. Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review.
Kubáň P; Foret F
Anal Chim Acta; 2013 Dec; 805():1-18. PubMed ID: 24296139
[TBL] [Abstract][Full Text] [Related]
20. Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers.
Hillas G; Kostikas K; Mantzouranis K; Bessa V; Kontogianni K; Papadaki G; Papiris S; Alchanatis M; Loukides S; Bakakos P
Respirology; 2011 Jul; 16(5):811-8. PubMed ID: 21545371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
